Tigermed的封面图片
Tigermed

Tigermed

制药业

Hangzhou,Zhejiang 57,508 位关注者

Excellence. In every trial. For every patient.

关于我们

Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.

所属行业
制药业
规模
5,001-10,000 人
总部
Hangzhou,Zhejiang
类型
上市公司
创立
2004
领域
BE study Generic Drugs Quality Consistency Evaluation、Preclinical/CMC/Bioanalytical、Clinical related services、Regulatory Affairs、Clinical trial---Phase I to IV & NIS和MART&Oversea clinical service

地点

  • 主要

    No.19 Jugong Road, Binjiang District

    F18, Building A – Shengda Science Park

    CN,Zhejiang,Hangzhou,310053

    获取路线
  • Changning District, Shanghai,P.R.China

    Fl.16,999 West Zhongshan Road,

    CN,Shanghai,Shanghai,200051

    获取路线
  • No.20 Chaoyangmen Outer Street,Chaoyang District, Beijing,P.R.China

    Room 808,Union Mansion

    CN,Beijing,Beijing,100020

    获取路线

Tigermed员工

动态

相似主页

融资

Tigermed 共 2 轮

上一轮

未知

US$2,000,000.00

Crunchbase 上查看更多信息